Publications in collaboration with researchers from Hospital Universitario Puerta de Hierro (2)

2006

  1. R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB2 receptor

    Biochemical Pharmacology, Vol. 72, Núm. 12, pp. 1697-1706

2001

  1. Inhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptor

    Cancer Research, Vol. 61, Núm. 15, pp. 5784-5789